XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2018     66,569      
Beginning balance at Dec. 31, 2018 $ 211,689   $ 7 $ 117,763 $ 93,919  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11,502       11,502  
Dividends declared (5,402)       (5,402)  
Dividend equivalents on unvested performance-based restricted stock awards 0     27 (27)  
Dividend equivalents canceled upon forfeiture of performance-based restricted stock awards 0     (122) 122  
Restricted stock vestings (in shares)     364      
Restricted stock vestings 0          
Shares surrendered and cancelled upon vesting of restricted stock to satisfy tax withholdings (in shares)     (153)      
Shares surrendered and canceled upon vesting of restricted stock to satisfy tax withholdings (2,609)     (2,609)    
Stock-based compensation 2,272     2,272    
Shares issuable in lieu of dividend payments on performance-based restricted stock awards (in shares)     3      
Shares issuable in lieu of dividend payments on performance-based restricted stock awards 0          
Issuance of common stock under employee stock purchase plan (in shares)     128      
Issuance of common stock under employee stock purchase plan 1,443     1,443    
Ending balance (in shares) at Mar. 31, 2019     66,911      
Ending balance at Mar. 31, 2019 218,895   $ 7 118,774 100,114  
Beginning balance (in shares) at Dec. 31, 2018     66,569      
Beginning balance at Dec. 31, 2018 211,689   $ 7 117,763 93,919  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 25,962          
Ending balance (in shares) at Jun. 30, 2019     66,956      
Ending balance at Jun. 30, 2019 229,342   $ 7 120,204 109,131  
Beginning balance (in shares) at Mar. 31, 2019     66,911      
Beginning balance at Mar. 31, 2019 218,895   $ 7 118,774 100,114  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 14,460       14,460  
Dividends declared (5,416)       (5,416)  
Dividend equivalents on unvested performance-based restricted stock awards 0     27 (27)  
Restricted stock vestings (in shares)     47      
Restricted stock vestings 0          
Shares surrendered and cancelled upon vesting of restricted stock to satisfy tax withholdings (in shares)     (2)      
Shares surrendered and canceled upon vesting of restricted stock to satisfy tax withholdings (28)     (28)    
Stock-based compensation 1,431     1,431    
Ending balance (in shares) at Jun. 30, 2019     66,956      
Ending balance at Jun. 30, 2019 $ 229,342   $ 7 120,204 109,131  
Beginning balance (in shares) at Dec. 31, 2019 66,968   66,968      
Beginning balance at Dec. 31, 2019 $ 245,928 $ 339 $ 7 123,208 122,713 $ 339
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11,863       11,863  
Dividends declared (6,105)       (6,105)  
Dividend equivalents on unvested performance-based restricted stock awards 0     35 (35)  
Dividend equivalents canceled upon forfeiture of performance-based restricted stock awards 0     (84) 84  
Restricted stock vestings (in shares)     228      
Restricted stock vestings 0          
Shares surrendered and cancelled upon vesting of restricted stock to satisfy tax withholdings (in shares)     (91)      
Shares surrendered and canceled upon vesting of restricted stock to satisfy tax withholdings (1,865)     (1,865)    
Repurchase of shares (in shares)     (241)      
Repurchase of shares (3,944)     (439) (3,505)  
Stock-based compensation 1,319     1,319    
Issuance of common stock under employee stock purchase plan (in shares)     104      
Issuance of common stock under employee stock purchase plan 1,509     1,509    
Ending balance (in shares) at Mar. 31, 2020     66,968      
Ending balance at Mar. 31, 2020 $ 249,044   $ 7 123,683 125,354  
Beginning balance (in shares) at Dec. 31, 2019 66,968   66,968      
Beginning balance at Dec. 31, 2019 $ 245,928 $ 339 $ 7 123,208 122,713 $ 339
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 25,659          
Ending balance (in shares) at Jun. 30, 2020 67,019   67,019      
Ending balance at Jun. 30, 2020 $ 258,429   $ 7 125,404 133,018  
Beginning balance (in shares) at Mar. 31, 2020     66,968      
Beginning balance at Mar. 31, 2020 249,044   $ 7 123,683 125,354  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 13,796       13,796  
Dividends declared (6,097)       (6,097)  
Dividend equivalents on unvested performance-based restricted stock awards 0     35 (35)  
Restricted stock vestings (in shares)     53      
Restricted stock vestings 0          
Shares surrendered and cancelled upon vesting of restricted stock to satisfy tax withholdings (in shares)     (2)      
Shares surrendered and canceled upon vesting of restricted stock to satisfy tax withholdings (53)     (53)    
Stock-based compensation $ 1,739     1,739    
Ending balance (in shares) at Jun. 30, 2020 67,019   67,019      
Ending balance at Jun. 30, 2020 $ 258,429   $ 7 $ 125,404 $ 133,018